MUMBAI, India, June 27 -- Intellectual Property India has published a patent application (202517053522 A) filed by Aktis Oncology, Inc., Boston, on June 2, for 'decreased retention of miniproteins in kidney.'
Inventor(s) include Blackwell III, William C; Srivastava, Ved; Goodman, Brian; Feldman, Paul L; Way, James M.; Kovacs, Jeff; Kil, Hyun Joo; Gober, Isaiah Nathaniel; Doligalski, Michael Lawrence; and Kosciuk, Tatsiana.
The application for the patent was published on June 27, under issue no. 26/2025.
According to the abstract released by the Intellectual Property India: "Provided herein are compositions and methods of treating, diagnosing, monitoring, and/or imaging a disease, disorder, or condition using radiopharmaceuticals selective for various targets. More specifically, compositions and methods disclosed herein decrease kidney retention or potential reuptake in the kidney where the targets are expressed in the kidney. Various approaches are disclosed to mitigate kidney retention of radiopharmaceuticals."
The patent application was internationally filed on Nov. 14, 2023, under International application No.PCT/US2023/079693.
Disclaimer: Curated by HT Syndication.
